PFE

Pfizer Inc

Oct 15 • 04:00PM ET

24.39

-0.13 -0.53 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	12.97	EPS (ttm)	1.88	Insider Own	0.11%	Shs Outstand	5.68B	Perf Week	-5.02%
Market Cap	138.67B	Forward P/E	7.75	EPS next Y	3.15	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	2.05%
Enterprise Value	187.54B	PEG	-	EPS next Q	0.65	Inst Own	66.78%	Short Float	2.01%	Perf Quarter	-0.77%
Income	10.73B	P/S	2.17	EPS this Y	-1.83%	Inst Trans	-0.58%	Short Ratio	2.32	Perf Half Y	8.69%
Sales	63.83B	P/B	1.56	EPS next Y	3.03%	ROA	5.08%	Short Interest	113.95M	Perf YTD	-8.07%
Book/sh	15.60	P/C	10.47	EPS next 5Y	-0.05%	ROE	12.16%	52W High	29.82 -18.21%	Perf Year	-16.36%
Cash/sh	2.33	P/FCF	11.15	EPS past 3/5Y	-28.69% -13.27%	ROIC	7.34%	52W Low	20.92 16.61%	Perf 3Y	-41.58%
Dividend Est.	1.70 (6.97%)	EV/EBITDA	7.30	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	67.34%	Volatility	2.03% 2.54%	Perf 5Y	-30.23%
Dividend TTM	1.71 (7.01%)	EV/Sales	2.94	EPS Y/Y TTM	510.84%	Oper. Margin	29.60%	ATR (14)	0.60	Perf 10Y	-22.69%
Dividend Ex-Date	Nov 07, 2025	Quick Ratio	0.85	Sales Y/Y TTM	14.72%	Profit Margin	16.81%	RSI (14)	43.30	Recom	2.48
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.16	EPS Q/Q	11938.10%	SMA20	-2.60%	Beta	0.51	Target Price	28.74
Payout	120.11%	Debt/Eq	0.70	Sales Q/Q	10.31%	SMA50	-1.95%	Rel Volume	0.97	Prev Close	24.52
Employees	81000	LT Debt/Eq	0.65	Earnings	Nov 04 BMO	SMA200	-1.63%	Avg Volume	49.20M	Price	24.39
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	34.39% 8.06%	Trades		Volume	47,618,059	Change	-0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Oct-15-25 08:40AM	Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026? (Zacks)
07:40AM	Pfizer touts Tukysa in front-line breast cancer after Phase III victory (Pharmaceutical Technology)
Oct-14-25 05:10PM	Health Care Roundup: Market Talk (The Wall Street Journal)
01:33PM	Top Novavax Shareholder Demands Company's Sale (Barrons.com)
10:38AM	CorMedix Stock Plunges 16% in a Month: Should Investors Buy the Dip? (Zacks)
10:01AM	Loading…
10:01AM	BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? (Zacks)
08:43AM	Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping. (Barrons.com)
06:45AM	TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial (Business Wire)
06:20AM	Johnson & Johnson Says It Will Spin Off Orthopaedics Business (Barrons.com)
Oct-13-25 11:16PM	Pfizer's (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock (Insider Monkey)
05:04PM	This Pharma Play, The IBD Stock Of The Day, Is Offering Another Entry Amid 100% Advance This Year (Investor's Business Daily)
03:24PM	Trump's AstraZeneca Deal Echoes Pfizer Pact. Big Pharma's Political Headaches Are Easing. (Barrons.com)
02:50PM	Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal (Zacks)
01:40PM	AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve (Zacks)
10:57AM	New US biotech hubs showing potential amid onshoring request (Pharmaceutical Technology)
10:36AM	Loading…
10:36AM	Analyst Report: Zoetis Inc. (Morningstar Research)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
08:45AM	Where Will Pfizer Be in 5 Years? (Motley Fool)
06:45AM	Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 (Business Wire)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
05:30AM	Why Biotech's Rally Can Last This Time (The Wall Street Journal)
Oct-12-25 02:28PM	4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer (Motley Fool)
Oct-11-25 07:00AM	MarketBeat Week in Review - 10/06 - 10/10 (MarketBeat)
Oct-10-25 08:27PM	AstraZeneca Cuts Discounted Drug Pricing Deal With the White House. The Stock Is Rising. (Barrons.com)
08:18PM	Biotech Stocks Have Struggled Since 2021. Why They're Coming Back. (Barrons.com)
07:11PM	AstraZeneca Strikes Drug-Pricing Deal With Trump Administration (The Wall Street Journal)
06:39PM	Trump reaches deal with AstraZeneca to lower U.S. drug prices (CNBC TV)
06:09PM	AstraZeneca becomes latest drugmaker to strike deal with Trump. Its stock is climbing after hours. (MarketWatch)
05:58PM	Trump Announces AstraZeneca Drug Price Cuts for Tariff Reprieve (Bloomberg)
04:38PM	AstraZeneca to Ink Drug-Pricing Deal With Trump Administration (The Wall Street Journal)
12:19PM	Loading…
12:19PM	Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. (Barrons.com)
06:45AM	2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now (Motley Fool)
05:32AM	Pharma R&D set to endure despite rising MFN costs (Clinical Trials Arena)
03:18AM	Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors? (Motley Fool)
Oct-09-25 05:45PM	Here's Why Pfizer (PFE) Fell More Than Broader Market (Zacks)
04:30PM	Pfizer Declares Fourth-Quarter 2025 Dividend (Business Wire)
03:26PM	A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here's Who It Is. (Barrons.com)
08:03AM	5 Healthcare Plays Powering the Sector's Big Comeback (MarketBeat)
Oct-08-25 04:19PM	Here Are the 12 Best Buyback Aristocrat Stocks (Barrons.com)
04:19PM	Here Are the 12 Best 'Buyback Aristocrats' (Barrons.com)
02:48PM	Finally, Tariffs the Stock Market Likes. Why Pharma Levies May Do the Trick. (Barrons.com)
11:28AM	Should You Buy Pfizer (PFE) Before a Breakout Begins? (Insider Monkey)
08:50AM	Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings (Zacks)
08:42AM	3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal (Zacks)
07:16AM	Why AbbVie and Johnson & Johnson Could Outperform Pfizer (MarketBeat)
Oct-07-25 05:04PM	Former Top FDA Official, Forced Out by Kennedy, Lands at Eli Lilly (Barrons.com)
01:45PM	Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% (Zacks)
10:32AM	Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In? (Zacks)
10:06AM	The No. 1 Investing Mistake to Avoid As Washington Grinds to a Halt (Motley Fool)
09:30AM	Down 50%, Should You Buy the Dip on Pfizer? (Motley Fool)
09:25AM	The Zacks Analyst Blog Highlights Delta Airlines, Levi Strauss, Pfizer, Zoom Communications , Fresnillo and Kyocera (Zacks)
08:27AM	Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock? (Zacks)
07:11AM	Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? (Revised) (Zacks)
07:04AM	TrumpRx Brings Pfizer Into the Green-Is It a Buy? (MarketBeat)
06:14AM	Venture financing for mRNA-based vaccines declines 82% in 2025 YTD (Pharmaceutical Technology)
06:00AM	Hiltzik: There's much less than meets the eye in Trump's 'historic' drug price deal with Pfizer (LA Times)
03:15AM	Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500 (Motley Fool)
Oct-06-25 07:34PM	Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal (MarketBeat)
02:21PM	Trump's Drug Price Cuts: Boom or Bust for These 3 Pharma Giants (MarketBeat)
01:57PM	Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know (Zacks)
12:10PM	Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? (Zacks)
11:33AM	Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. (Barrons.com)
10:11AM	AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week? (Zacks)
09:03AM	Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk (Zacks)
09:00AM	Trump says the US has secured $17 trillion in new investments. The real number is likely much less (Associated Press Finance)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
06:57AM	4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio (Zacks)
04:59AM	3 Reasons to Buy Pfizer Stock Now (Motley Fool)
03:32AM	Trump administration could lower drug prices by making other nations pay more (Pharma Voice)
Oct-05-25 01:42PM	3 Dirt Cheap Stocks to Buy in a Market Priced for Perfection (Motley Fool)
09:15AM	Can Pfizer's Stock Break This Disappointing Streak? (Motley Fool)
04:47AM	Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks. (Motley Fool)
02:42AM	Bank of America Securities Maintains Buy on Pfizer Inc (PFE) (Insider Monkey)
Oct-04-25 09:00AM	Legal threats are pushing Trump's tariff strategy in new directions. Don't expect more certainty. (Yahoo Finance)
07:02AM	Tech stocks roll on and Pfizer soars after Trump deal (Detroit Free Press)
05:27AM	Investing.coms stocks of the week (Investing.com)
Oct-03-25 06:40PM	When It Comes to Healthcare, Think Big (Barrons.com)
05:45PM	Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know (Zacks)
05:17PM	The Score: Pfizer, Tesla, Electronic Arts and More Stocks That Defined the Week (The Wall Street Journal)
04:55PM	5 Large Cap Drug Stocks: Values or Traps? (Zacks)
04:51PM	Pharma Stocks Eye Best Week in 16 Years as Trump Overhang Eases (Bloomberg)
12:33PM	Trump administration announces MFN drug pricing deal with Pfizer (Pharmaceutical Technology)
12:02PM	Intel, Nvidia and the 'Visible Hand' of Trump Capitalism (Barrons.com)
11:55AM	Detroit Carmakers Feud Over Trumps Threatened Truck Tariffs (Bloomberg)
11:48AM	Palantir, AI bubble comments, pharma stocks: Trending Tickers (Yahoo Finance Video)
10:16AM	Wells Fargo sees room to run for Johnson & Johnson, highlights pharma upside (Investing.com)
10:06AM	MRK Stock Up Nearly 14% So Far This Week: What's Driving It? (Zacks)
09:59AM	Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump? (Zacks)
07:48AM	Pfizers Drug-Price Deal With Trump Ended Months of Deadlock (Bloomberg)
06:27AM	Cantor Fitzgerald Maintains a Hold on Pfizer (PFE) (Insider Monkey)
04:20AM	These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True? (Motley Fool)
03:48AM	2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October (Motley Fool)
03:15AM	Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy? (Motley Fool)
Oct-02-25 09:16PM	Inside Pfizer's Drug-Pricing Deal With the Trump Administration (The Wall Street Journal)
12:52PM	Buy Novo Nordisk Stock as Health Names Return to Favor, Analyst Says (Barrons.com)
12:22PM	AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy? (Motley Fool)
10:32AM	Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? (Zacks)
07:02AM	3 Things You Need to Know if You Buy Pfizer Today (Motley Fool)
07:00AM	Why Pfizer's Trump Deal Is Good News for All of Big Pharma (The Wall Street Journal)
05:11AM	3 Mega Dividend Stocks With Yields as High as 13.4% (Motley Fool)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience